ClinicalTrials.gg

Program

Tin Fluorides

Also written as “0.454% Stannous Fluoride Dentifrice”, “Stannous fluoride toothpaste” and “Stannous Fluoride”.

Its studies are mostly in Gingivitis · Dentin Sensitivity · Dental Plaque · Diabetes Mellitus, Type 2 · Halitosis, led by 5 companies.

Furthest: phase 4, since Feb 6, 201547 company-led studies, 4 open or runningNext primary completion: Sep 2027 (phase 4)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Colgate Palmolive182 open or runningphase 4since Feb 6, 2015Sep 26, 2008Sep 2027phase 4 · NCT07807397
Procter and Gamble142 open or runningphase 4since Aug 28, 2025Feb 28, 2012none ahead
GlaxoSmithKline80 open or runningphase 3since May 3, 2012May 3, 2012none ahead
HALEON40 open or runningno phasesince Nov 16, 2023Nov 16, 2023none ahead
Church & Dwight30 open or runningno phasesince Feb 12, 2026Feb 12, 2026none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 31 studies since Sep 26, 2008.

  1. Oct 23, 2024No phase study in Gingival DiseasesProcter and Gamble · NCT06659471 · 120 enrolled · United States
  2. Oct 24, 2024No phase study in Dental PlaqueHALEON · NCT06660069 · 199 enrolled · United States
  3. Apr 30, 2025Phase 1 study in GingivitisProcter and Gamble · NCT06962956 · 135 enrolled · United States
  4. Aug 28, 2025Phase 4 study in GingivitisProcter and Gamble · NCT07158112 · 120 enrolled · United States
  5. Sep 29, 2025Phase 4 study in GingivitisProcter and Gamble · NCT07211061 · 69 enrolled · United States
  6. Oct 29, 20252 phase 3 studiesColgate Palmolive · NCT07223073, NCT07223060
  7. Jan 27, 2026Phase 3 study in Plaque, AmyloidColgate Palmolive · NCT07398846 · 134 enrolled · United States
  8. Feb 12, 2026Church & Dwight's first studies: 2 no phase studiesNew to Church & DwightChurch & Dwight · NCT07419737, NCT07425509
  9. Mar 4, 2026Phase 3 study in Plaque, AmyloidColgate Palmolive · NCT07458464 · 95 enrolled · Thailand
  10. May 26, 2026Phase 4 study in Diabetes Mellitus, Type 2Colgate Palmolive · NCT07619729 · 10,000 planned · United States
  11. Jun 2, 2026No phase study in GingivitisChurch & Dwight · NCT07640399 · 133 enrolled · Canada
  12. Jul 26, 2026Phase 3 study in Dental HypersensitivityColgate Palmolive · NCT07738198 · 116 enrolled · United States
  13. Sep 2, 2026Phase 4 study in Periodontal DiseasesColgate Palmolive · NCT07807397 · 500 planned
  14. Oct 29, 2026Phase 3 study in Plaque, AmyloidColgate Palmolive · NCT07917507 · 84 enrolled · Dominican Republic

Ahead

  1. Sep 2027Primary completion: phase 4 study in Periodontal DiseasesColgate Palmolive · NCT07807397
  2. Jan 2, 2028Primary completion: phase 4 study in Diabetes Mellitus, Type 2Colgate Palmolive · NCT07619729

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 47 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusLed byPrimary completionSize
NCT07917507Plaque, Amyloid · Dominican Republic3CompletedColgate PalmoliveNov 4, 202684
NCT07807397Periodontal Diseases4Not yet recruitingColgate PalmoliveSep 2027500
NCT07738198Dental Hypersensitivity · United States3CompletedColgate PalmoliveDec 8, 2018116
NCT07640399Gingivitis · Canada–CompletedChurch & DwightJun 13, 2025133
NCT07619729Diabetes Mellitus, Type 2 · United States4By invitationColgate PalmoliveJan 2, 202810,000
NCT07458464Plaque, Amyloid · Thailand3CompletedColgate PalmoliveJun 28, 202695
NCT07425509Halitosis · United States–CompletedChurch & DwightNov 4, 202449
NCT07419737Dental Plaque · United States–CompletedChurch & DwightDec 4, 202491
NCT07398846Plaque, Amyloid · United States3CompletedColgate PalmoliveApr 29, 2026134
NCT07223073Oral Malodor · Thailand3CompletedColgate PalmoliveJan 12, 201880
NCT07223060Dental Calculus · Thailand3CompletedColgate PalmoliveOct 6, 2017100
NCT07211061Gingivitis · United States4CompletedProcter and GambleNov 10, 201169
NCT07158112Gingivitis · United States4Active, not recruitingProcter and GambleDec 7, 2025120
NCT06962956Gingivitis · United States1Active, not recruitingProcter and GambleOct 31, 2025135
NCT06660069Dental Plaque · United States–CompletedHALEONMar 11, 2025199
NCT06659471Gingival Diseases · United States–CompletedProcter and GambleJun 6, 2022120
NCT06427499Plaque, Amyloid · Thailand3CompletedColgate PalmoliveAug 5, 202495
NCT06354270Dentin Sensitivity · United States–CompletedHALEONJun 23, 2024115
NCT06359028Dentin Sensitivity · United States–CompletedHALEONJun 20, 2024111
NCT06353165Dental Plaque · Thailand3CompletedColgate PalmoliveApr 12, 2023100
NCT06242769Tooth Stain Removal · Puerto Rico3CompletedColgate PalmoliveSep 14, 202080
NCT06143670Gingivitis · United States–CompletedHALEONMar 12, 2024159
NCT06140784Gingivitis · United States–CompletedProcter and GambleDec 10, 2023116
NCT06140771Gingivitis · United States–CompletedProcter and GambleFeb 6, 2022115
NCT06140758Caries · Australia–CompletedProcter and GambleDec 11, 202312
NCT05326373Gingivitis · United States–CompletedProcter and GambleJun 13, 202240
NCT04123665Gingivitis · United States3CompletedGlaxoSmithKlineDec 11, 201398
NCT05731778Gingivitis · Canada4CompletedColgate PalmoliveDec 22, 202026
NCT04033575Gingivitis · United States4CompletedColgate PalmoliveJun 6, 201988
NCT03852056Dental Plaque · China3CompletedColgate PalmoliveDec 7, 201798
NCT03296657Subgingival Plaque · United States–CompletedProcter and GambleSep 22, 201720
NCT03072719Dentin Sensitivity · Ireland3CompletedGlaxoSmithKlineJun 1, 2012120
NCT02841839Subgingival Plaque–CompletedProcter and GambleJun 201620
NCT02752958Dentin Sensitivity · United Kingdom–CompletedGlaxoSmithKlineFeb 1, 201775
NCT02832375Dentin Sensitivity · United States3CompletedGlaxoSmithKlineMay 1, 2016242
NCT02613130Oral Malodor · United States–CompletedProcter and GambleDec 201560
NCT02750943Gingivitis · United States–CompletedGlaxoSmithKlineMar 1, 2016253
NCT02574221Plaque, Amyloid · United States–CompletedProcter and GambleOct 201560
NCT02543060Plaque, Amyloid · United States–CompletedProcter and GambleAug 201560
NCT02366689Dental Plaque · United States4CompletedColgate PalmoliveDec 2014179
NCT02360995Dental Plaque · United States4CompletedColgate PalmoliveAug 2014129
NCT02193165Dental Plaque · Puerto Rico3CompletedColgate PalmoliveAug 2014120
NCT01827670Dentin Sensitivity · United States3CompletedGlaxoSmithKlineMay 2013119
NCT01592864Dentin Sensitivity · United States3CompletedGlaxoSmithKlineMay 2012120
NCT01592851Dentin Sensitivity · United States3CompletedGlaxoSmithKlineMay 2012113
NCT01549587Gingivitis · United States–CompletedProcter and GambleFeb 2014746
NCT00762177Oral Bacteria · United States3CompletedColgate PalmoliveSep 200824

How it is read

Names in the registry

  • “0.454% Stannous Fluoride Dentifrice”, 8 entries
  • “Stannous fluoride toothpaste”, 7 entries
  • “Stannous Fluoride”, 6 entries
  • “stannous fluoride toothpaste”, 5 entries
  • “Stannous Fluoride Toothpaste (SnF)”, 5 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.